Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Peyronies Disease Treatment
1.2 Classification of Peyronies Disease Treatment by Type
1.2.1 Overview: Global Peyronies Disease Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Peyronies Disease Treatment Revenue Market Share by Type in 2021
1.2.3 Drugs
1.2.4 Surgery
1.3 Global Peyronies Disease Treatment Market by Application
1.3.1 Overview: Global Peyronies Disease Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Global Peyronies Disease Treatment Market Size & Forecast
1.5 Global Peyronies Disease Treatment Market Size and Forecast by Region
1.5.1 Global Peyronies Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Peyronies Disease Treatment Market Size by Region, (2017-2022)
1.5.3 North America Peyronies Disease Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Peyronies Disease Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Peyronies Disease Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Peyronies Disease Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Peyronies Disease Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Peyronies Disease Treatment Market Drivers
1.6.2 Peyronies Disease Treatment Market Restraints
1.6.3 Peyronies Disease Treatment Trends Analysis
2 Company Profiles
2.1 Endo International
2.1.1 Endo International Details
2.1.2 Endo International Major Business
2.1.3 Endo International Peyronies Disease Treatment Product and Solutions
2.1.4 Endo International Peyronies Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Endo International Recent Developments and Future Plans
2.2 Asahi Kasei
2.2.1 Asahi Kasei Details
2.2.2 Asahi Kasei Major Business
2.2.3 Asahi Kasei Peyronies Disease Treatment Product and Solutions
2.2.4 Asahi Kasei Peyronies Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Asahi Kasei Recent Developments and Future Plans
2.3 BioSpecifics Technologies
2.3.1 BioSpecifics Technologies Details
2.3.2 BioSpecifics Technologies Major Business
2.3.3 BioSpecifics Technologies Peyronies Disease Treatment Product and Solutions
2.3.4 BioSpecifics Technologies Peyronies Disease Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 BioSpecifics Technologies Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Peyronies Disease Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Peyronies Disease Treatment Players Market Share in 2021
3.2.2 Top 10 Peyronies Disease Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Peyronies Disease Treatment Players Head Office, Products and Services Provided
3.4 Peyronies Disease Treatment Mergers & Acquisitions
3.5 Peyronies Disease Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Peyronies Disease Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Peyronies Disease Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Peyronies Disease Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Peyronies Disease Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Peyronies Disease Treatment Revenue by Type (2017-2028)
6.2 North America Peyronies Disease Treatment Revenue by Application (2017-2028)
6.3 North America Peyronies Disease Treatment Market Size by Country
6.3.1 North America Peyronies Disease Treatment Revenue by Country (2017-2028)
6.3.2 United States Peyronies Disease Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Peyronies Disease Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Peyronies Disease Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Peyronies Disease Treatment Revenue by Type (2017-2028)
7.2 Europe Peyronies Disease Treatment Revenue by Application (2017-2028)
7.3 Europe Peyronies Disease Treatment Market Size by Country
7.3.1 Europe Peyronies Disease Treatment Revenue by Country (2017-2028)
7.3.2 Germany Peyronies Disease Treatment Market Size and Forecast (2017-2028)
7.3.3 France Peyronies Disease Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Peyronies Disease Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Peyronies Disease Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Peyronies Disease Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Peyronies Disease Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Peyronies Disease Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Peyronies Disease Treatment Market Size by Region
8.3.1 Asia-Pacific Peyronies Disease Treatment Revenue by Region (2017-2028)
8.3.2 China Peyronies Disease Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Peyronies Disease Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Peyronies Disease Treatment Market Size and Forecast (2017-2028)
8.3.5 India Peyronies Disease Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Peyronies Disease Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Peyronies Disease Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Peyronies Disease Treatment Revenue by Type (2017-2028)
9.2 South America Peyronies Disease Treatment Revenue by Application (2017-2028)
9.3 South America Peyronies Disease Treatment Market Size by Country
9.3.1 South America Peyronies Disease Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Peyronies Disease Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Peyronies Disease Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Peyronies Disease Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Peyronies Disease Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Peyronies Disease Treatment Market Size by Country
10.3.1 Middle East & Africa Peyronies Disease Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Peyronies Disease Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Peyronies Disease Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Peyronies Disease Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Peyronies Disease Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Peyronies Disease Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Peyronies Disease Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Peyronies Disease Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Peyronies Disease Treatment Revenue Market Share by Region (2023-2028)
Table 6. Endo International Corporate Information, Head Office, and Major Competitors
Table 7. Endo International Major Business
Table 8. Endo International Peyronies Disease Treatment Product and Solutions
Table 9. Endo International Peyronies Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Asahi Kasei Corporate Information, Head Office, and Major Competitors
Table 11. Asahi Kasei Major Business
Table 12. Asahi Kasei Peyronies Disease Treatment Product and Solutions
Table 13. Asahi Kasei Peyronies Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. BioSpecifics Technologies Corporate Information, Head Office, and Major Competitors
Table 15. BioSpecifics Technologies Major Business
Table 16. BioSpecifics Technologies Peyronies Disease Treatment Product and Solutions
Table 17. BioSpecifics Technologies Peyronies Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Global Peyronies Disease Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 19. Global Peyronies Disease Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 20. Breakdown of Peyronies Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 21. Peyronies Disease Treatment Players Head Office, Products and Services Provided
Table 22. Peyronies Disease Treatment Mergers & Acquisitions in the Past Five Years
Table 23. Peyronies Disease Treatment New Entrants and Expansion Plans
Table 24. Global Peyronies Disease Treatment Revenue (USD Million) by Type (2017-2022)
Table 25. Global Peyronies Disease Treatment Revenue Share by Type (2017-2022)
Table 26. Global Peyronies Disease Treatment Revenue Forecast by Type (2023-2028)
Table 27. Global Peyronies Disease Treatment Revenue by Application (2017-2022)
Table 28. Global Peyronies Disease Treatment Revenue Forecast by Application (2023-2028)
Table 29. North America Peyronies Disease Treatment Revenue by Type (2017-2022) & (USD Million)
Table 30. North America Peyronies Disease Treatment Revenue by Type (2023-2028) & (USD Million)
Table 31. North America Peyronies Disease Treatment Revenue by Application (2017-2022) & (USD Million)
Table 32. North America Peyronies Disease Treatment Revenue by Application (2023-2028) & (USD Million)
Table 33. North America Peyronies Disease Treatment Revenue by Country (2017-2022) & (USD Million)
Table 34. North America Peyronies Disease Treatment Revenue by Country (2023-2028) & (USD Million)
Table 35. Europe Peyronies Disease Treatment Revenue by Type (2017-2022) & (USD Million)
Table 36. Europe Peyronies Disease Treatment Revenue by Type (2023-2028) & (USD Million)
Table 37. Europe Peyronies Disease Treatment Revenue by Application (2017-2022) & (USD Million)
Table 38. Europe Peyronies Disease Treatment Revenue by Application (2023-2028) & (USD Million)
Table 39. Europe Peyronies Disease Treatment Revenue by Country (2017-2022) & (USD Million)
Table 40. Europe Peyronies Disease Treatment Revenue by Country (2023-2028) & (USD Million)
Table 41. Asia-Pacific Peyronies Disease Treatment Revenue by Type (2017-2022) & (USD Million)
Table 42. Asia-Pacific Peyronies Disease Treatment Revenue by Type (2023-2028) & (USD Million)
Table 43. Asia-Pacific Peyronies Disease Treatment Revenue by Application (2017-2022) & (USD Million)
Table 44. Asia-Pacific Peyronies Disease Treatment Revenue by Application (2023-2028) & (USD Million)
Table 45. Asia-Pacific Peyronies Disease Treatment Revenue by Region (2017-2022) & (USD Million)
Table 46. Asia-Pacific Peyronies Disease Treatment Revenue by Region (2023-2028) & (USD Million)
Table 47. South America Peyronies Disease Treatment Revenue by Type (2017-2022) & (USD Million)
Table 48. South America Peyronies Disease Treatment Revenue by Type (2023-2028) & (USD Million)
Table 49. South America Peyronies Disease Treatment Revenue by Application (2017-2022) & (USD Million)
Table 50. South America Peyronies Disease Treatment Revenue by Application (2023-2028) & (USD Million)
Table 51. South America Peyronies Disease Treatment Revenue by Country (2017-2022) & (USD Million)
Table 52. South America Peyronies Disease Treatment Revenue by Country (2023-2028) & (USD Million)
Table 53. Middle East & Africa Peyronies Disease Treatment Revenue by Type (2017-2022) & (USD Million)
Table 54. Middle East & Africa Peyronies Disease Treatment Revenue by Type (2023-2028) & (USD Million)
Table 55. Middle East & Africa Peyronies Disease Treatment Revenue by Application (2017-2022) & (USD Million)
Table 56. Middle East & Africa Peyronies Disease Treatment Revenue by Application (2023-2028) & (USD Million)
Table 57. Middle East & Africa Peyronies Disease Treatment Revenue by Country (2017-2022) & (USD Million)
Table 58. Middle East & Africa Peyronies Disease Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Peyronies Disease Treatment Picture
Figure 2. Global Peyronies Disease Treatment Revenue Market Share by Type in 2021
Figure 3. Drugs
Figure 4. Surgery
Figure 5. Peyronies Disease Treatment Revenue Market Share by Application in 2021
Figure 6. Hospital Picture
Figure 7. Drugs Store Picture
Figure 8. Global Peyronies Disease Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Peyronies Disease Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Peyronies Disease Treatment Revenue Market Share by Region (2017-2028)
Figure 11. Global Peyronies Disease Treatment Revenue Market Share by Region in 2021
Figure 12. North America Peyronies Disease Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Peyronies Disease Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Peyronies Disease Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Peyronies Disease Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Peyronies Disease Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Peyronies Disease Treatment Market Drivers
Figure 18. Peyronies Disease Treatment Market Restraints
Figure 19. Peyronies Disease Treatment Market Trends
Figure 20. Endo International Recent Developments and Future Plans
Figure 21. Asahi Kasei Recent Developments and Future Plans
Figure 22. BioSpecifics Technologies Recent Developments and Future Plans
Figure 23. Global Peyronies Disease Treatment Revenue Share by Players in 2021
Figure 24. Peyronies Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 25. Global Top 3 Players Peyronies Disease Treatment Revenue Market Share in 2021
Figure 26. Global Top 10 Players Peyronies Disease Treatment Revenue Market Share in 2021
Figure 27. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 28. Global Peyronies Disease Treatment Revenue Share by Type in 2021
Figure 29. Global Peyronies Disease Treatment Market Share Forecast by Type (2023-2028)
Figure 30. Global Peyronies Disease Treatment Revenue Share by Application in 2021
Figure 31. Global Peyronies Disease Treatment Market Share Forecast by Application (2023-2028)
Figure 32. North America Peyronies Disease Treatment Sales Market Share by Type (2017-2028)
Figure 33. North America Peyronies Disease Treatment Sales Market Share by Application (2017-2028)
Figure 34. North America Peyronies Disease Treatment Revenue Market Share by Country (2017-2028)
Figure 35. United States Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 36. Canada Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 37. Mexico Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 38. Europe Peyronies Disease Treatment Sales Market Share by Type (2017-2028)
Figure 39. Europe Peyronies Disease Treatment Sales Market Share by Application (2017-2028)
Figure 40. Europe Peyronies Disease Treatment Revenue Market Share by Country (2017-2028)
Figure 41. Germany Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. France Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. United Kingdom Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Russia Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Italy Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Asia-Pacific Peyronies Disease Treatment Sales Market Share by Type (2017-2028)
Figure 47. Asia-Pacific Peyronies Disease Treatment Sales Market Share by Application (2017-2028)
Figure 48. Asia-Pacific Peyronies Disease Treatment Revenue Market Share by Region (2017-2028)
Figure 49. China Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Japan Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. South Korea Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. India Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Southeast Asia Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Australia Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. South America Peyronies Disease Treatment Sales Market Share by Type (2017-2028)
Figure 56. South America Peyronies Disease Treatment Sales Market Share by Application (2017-2028)
Figure 57. South America Peyronies Disease Treatment Revenue Market Share by Country (2017-2028)
Figure 58. Brazil Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Argentina Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Middle East and Africa Peyronies Disease Treatment Sales Market Share by Type (2017-2028)
Figure 61. Middle East and Africa Peyronies Disease Treatment Sales Market Share by Application (2017-2028)
Figure 62. Middle East and Africa Peyronies Disease Treatment Revenue Market Share by Country (2017-2028)
Figure 63. Turkey Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Saudi Arabia Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. UAE Peyronies Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Methodology
Figure 67. Research Process and Data Source
Related reports :
(Jan 23)
According to our (Global Info Research) latest study, the global Particle Therapy System market size was valued at USD million in 2022 and i...
(Jan 23)
The bioabsorbable screw fixation had become the most common method of tibial graft fixation for all graft choices.
According to our (...
(Jan 23)
Hypothermia, a drop in body temperature, below 35 °C, can be caused due to accidental exposure, medical conditions, or could be on purpose a...
(Jan 23)
Increasing prevalence of chronic diseases and growing demand for the preventive measures are expected to fuel the preventive healthcare tech...
(Jan 23)
Medical Copper Tubing is used for medical gas/vacuum delivery, which conveys medical gas in healthcare facilities piping network. Type K and...
(Jan 23)
Duodenal Stents are flexible hollow tubes usually made of a thin metal wire which is woven into a mesh and may be covered in a plastic membr...